Repligen (NASDAQ:RGEN) Issues Quarterly Earnings Results

Repligen (NASDAQ:RGEN – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.49 by $0.04, Briefing.com reports. The firm had revenue of $159.20 million for the quarter, compared to the consensus estimate of $165.93 million. Repligen had a net margin […]

Related Keywords

United States ,America ,Martind Madaus ,Asia Pacific ,Craig Hallum ,Stifel Nicolaus ,Repligen Corporation ,Invesco Ltd ,Geode Capital Management ,Securities Exchange Commission ,Nasdaq ,Macquarie Group Ltd ,Get Free Report ,Director Martin ,Exchange Commission ,Street Corp ,Capital Management ,North America ,Repligen Daily ,